Sunshine Biopharma, Inc. SBFM
Set alert
2.93 USD -0.40 -12.01%
At close · Oct 30
2.66 -0.27 -9.22%
After hours · Oct 30, 7:57 PM ET
2.65 Day range 3.21
2.65 52-week range 358.00
- YTD
- -98.81%
- 1 year
- -99.16%
- Open
- 3.10
- Prev close
- 3.33
- Mkt cap
- 2.23M
- Vol
- 113.99K
- Avg vol
- 304.35K
- EPS
- -189.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.65
- High
- 3.21
- Forward P/E
- 0.02
- Beta
- -1.04
- Short ratio
- 0.39
- Inst. own
- 1.84%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.80
- 200-d avg
- 25.68
- 1y target
- 300.00
Ownership
Held by insiders 0.23%
Held by institutions 1.84%
Float held by institutions 1.85%
Institutions 11
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Bank of America Corporation | 1.72% | 34,480 | 103.44K | Sep 29, 2024 |
| Nordwand Advisors, LLC | 0.03% | 500 | 1.50K | Sep 29, 2024 |
| Rise Advisors, LLC | 0.00% | 1 | 3 | Sep 29, 2024 |
| Farther Finance Advisors, Llc | 0.00% | 1 | 3 | Sep 29, 2024 |
| National Bank of Canada/FI | 0.00% | 7 | 21 | Sep 29, 2024 |
| Federation Des Caisses Desjardins Du Quebec | 0.00% | 1 | 3 | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.00% | 11 | 33 | Aug 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| MERZOUKI ABDERRAZZAK | Chief Operating Officer | Stock Award(Grant) | Jan 5, 2021 | 23,342,500 |
| SEBAALY CAMILLE | Chief Financial Officer | Purchase | Nov 29, 2022 | 174,465 |
| SLILATY STEVE N | Chief Executive Officer | Stock Award(Grant) | Jan 5, 2021 | 23,343,500 |